Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies

Interstitial lung disease (ILD) is a leading cause of mortality in systemic sclerosis (SSc). However, mortality is improving as pathogenesis is being better understood and new therapies emerge. The roles of the inflammasome and NETosis in fibrosis are being elucidated. Epigenetic targets like DNA me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mediterr J Rheumatol
Hauptverfasser: Ahmed, Sakir, Pattanaik, Sarit Sekhar, Rai, Mohit Kumar, Nath, Alok, Agarwal, Vikas
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Mediterranean Journal of Rheumatology (MJR) 2018
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7046043/
https://ncbi.nlm.nih.gov/pubmed/32185315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.29.3.140
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge